
Clinical Research Management Briefing – April 9, 2018
Top Stories
NIH Moves to Punish Researchers Who Violate Confidentiality in Proposal Reviews
Sixty grant applications have been reevaluated after the National Institutes of Health (NIH) discovered violations of confidentiality during the review process.
Science, March 29
Phase 1 Trials: Therapy, Not Just Science
Better patient selection processes and cancer therapy outcomes support increased participation in phase 1 clinical trials.
Cancer Therapy Advisor, April 4
Regulatory
Cancer Researchers Push to Relax Rules for Clinical Trials
Later this month, the US Food and Drug Administration (FDA) will review eligibility criteria to reduce barriers for patients to participate in clinical trials.
Nature, April 3
Mandated Restructuring of Informed Consent Documents Could Help Guide Patient Decision-Making
New requirements in the revised Common Rule seek to change consent forms so they provide more simplified and concise information to patients participating in clinical trials.
Center Watch, April 2
Technology
Cambridge Analytica Controversy Must Spur Researchers to Update Data Ethics
Increased access to big data raises ethical questions about how it should be used by researchers.
Nature, March 27
The Government Wants to Free Your Health Data. Will That Unleash Innovation?
Improving access to patient data could lead to major scientific progress – only if patient records are secure and shareable.
STAT, March 29
Contact UsSubscribe to Huron Insights
Sign Up Today!Clinical Research Management Briefing – April 9, 2018
-
Rick Rohrbach
Managing Director
Industry:
Higher Education | Healthcare | Technology Media and Telecommunications | Life Sciences | Retail
-
Leah Guidry
Managing Director
Industry:
Higher Education | Healthcare | Life Sciences